Capex / revenue moved 791 bp lower
Capex / revenue changed -791 basis points from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Capex / revenue changed -791 basis points from the comparable as-filed period.
Capital expenditure changed -99.0% from the comparable as-filed period. The change ranks at the 80th percentile of 5 prior comparable changes.
Cash & equivalents changed +55.4% from the comparable as-filed period.
Free-cash-flow proxy changed +93.5% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Gross margin changed +1144 basis points from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Gross profit changed +6743.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Net income changed +708.8% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating cash flow changed +92.0% from the comparable as-filed period. The change ranks at the 43th percentile of 7 prior comparable changes.
Operating margin changed +4427 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Revenue changed +250.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Inventory changed +7.9% from the comparable as-filed period.
Operating income changed -7.8% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.